CNY 5.41
(3.24%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 63.06 Billion CNY | -0.82% |
2022 | 63.58 Billion CNY | 8.02% |
2021 | 58.86 Billion CNY | 6.62% |
2020 | 55.2 Billion CNY | 12.25% |
2019 | 49.18 Billion CNY | 6.24% |
2018 | 46.29 Billion CNY | 42.39% |
2017 | 32.51 Billion CNY | 21.68% |
2016 | 26.71 Billion CNY | 17.5% |
2015 | 22.73 Billion CNY | 41.79% |
2014 | 16.03 Billion CNY | 20.98% |
2013 | 13.25 Billion CNY | 32.99% |
2012 | 9.96 Billion CNY | 32.29% |
2011 | 7.53 Billion CNY | 82.88% |
2010 | 4.12 Billion CNY | -25.02% |
2009 | 5.49 Billion CNY | 29.55% |
2008 | 4.24 Billion CNY | 34.95% |
2007 | 3.14 Billion CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 68.2 Billion CNY | 0.51% |
2024 Q2 | 67.86 Billion CNY | 2.23% |
2024 Q1 | 66.38 Billion CNY | 5.25% |
2023 Q3 | 64.63 Billion CNY | -0.65% |
2023 Q4 | 63.06 Billion CNY | -2.42% |
2023 FY | 63.06 Billion CNY | -0.82% |
2023 Q1 | 67.21 Billion CNY | 5.7% |
2023 Q2 | 65.05 Billion CNY | -3.21% |
2022 FY | 63.58 Billion CNY | 8.02% |
2022 Q2 | 62.98 Billion CNY | 3.06% |
2022 Q1 | 61.11 Billion CNY | 3.83% |
2022 Q3 | 64.8 Billion CNY | 2.89% |
2022 Q4 | 63.58 Billion CNY | -1.89% |
2021 Q4 | 58.86 Billion CNY | -1.62% |
2021 Q1 | 55.88 Billion CNY | 1.23% |
2021 FY | 58.86 Billion CNY | 6.62% |
2021 Q2 | 57.29 Billion CNY | 2.53% |
2021 Q3 | 59.83 Billion CNY | 4.42% |
2020 Q3 | 53.8 Billion CNY | 7.4% |
2020 Q2 | 50.09 Billion CNY | -0.26% |
2020 Q1 | 50.23 Billion CNY | 2.14% |
2020 FY | 55.2 Billion CNY | 12.25% |
2020 Q4 | 55.2 Billion CNY | 2.6% |
2019 Q2 | 46.43 Billion CNY | 2.94% |
2019 FY | 49.18 Billion CNY | 6.24% |
2019 Q4 | 49.18 Billion CNY | 4.04% |
2019 Q1 | 45.1 Billion CNY | -2.55% |
2019 Q3 | 47.26 Billion CNY | 1.8% |
2018 FY | 46.29 Billion CNY | 42.39% |
2018 Q3 | 41.25 Billion CNY | 10.74% |
2018 Q2 | 37.25 Billion CNY | -7.38% |
2018 Q1 | 40.21 Billion CNY | 23.71% |
2018 Q4 | 46.29 Billion CNY | 12.21% |
2017 Q3 | 32.25 Billion CNY | 5.9% |
2017 Q2 | 30.45 Billion CNY | 3.47% |
2017 Q1 | 29.43 Billion CNY | 10.16% |
2017 FY | 32.51 Billion CNY | 21.68% |
2017 Q4 | 32.51 Billion CNY | 0.81% |
2016 Q1 | 25.5 Billion CNY | 12.17% |
2016 Q3 | 26.04 Billion CNY | 1.68% |
2016 Q4 | 26.71 Billion CNY | 2.6% |
2016 Q2 | 25.6 Billion CNY | 0.4% |
2016 FY | 26.71 Billion CNY | 17.5% |
2015 Q2 | 19.69 Billion CNY | 5.87% |
2015 Q1 | 18.6 Billion CNY | 16.01% |
2015 FY | 22.73 Billion CNY | 41.79% |
2015 Q4 | 22.73 Billion CNY | 7.31% |
2015 Q3 | 21.19 Billion CNY | 7.58% |
2014 Q1 | 13.08 Billion CNY | -1.3% |
2014 Q4 | 16.03 Billion CNY | 4.95% |
2014 Q3 | 15.28 Billion CNY | 3.84% |
2014 FY | 16.03 Billion CNY | 20.98% |
2014 Q2 | 14.71 Billion CNY | 12.47% |
2013 Q3 | 12.47 Billion CNY | 7.2% |
2013 FY | 13.25 Billion CNY | 32.99% |
2013 Q2 | 11.63 Billion CNY | 6.5% |
2013 Q4 | 13.25 Billion CNY | 6.28% |
2013 Q1 | 10.92 Billion CNY | 9.61% |
2012 FY | 9.96 Billion CNY | 32.29% |
2012 Q2 | 8.99 Billion CNY | 0.33% |
2012 Q3 | 9.67 Billion CNY | 7.51% |
2012 Q4 | 9.96 Billion CNY | 3.04% |
2012 Q1 | 8.96 Billion CNY | 19.01% |
2011 Q4 | 7.53 Billion CNY | 15.13% |
2011 Q1 | 5.26 Billion CNY | 27.89% |
2011 FY | 7.53 Billion CNY | 82.88% |
2011 Q3 | 6.54 Billion CNY | 9.69% |
2011 Q2 | 5.96 Billion CNY | 13.23% |
2010 Q2 | 5.44 Billion CNY | 0.0% |
2010 FY | 4.12 Billion CNY | -25.02% |
2010 Q4 | 4.12 Billion CNY | 0.0% |
2009 FY | 5.49 Billion CNY | 29.55% |
2008 FY | 4.24 Billion CNY | 34.95% |
2007 FY | 3.14 Billion CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 842.28 Million CNY | -7387.729% |
LBX Pharmacy Chain Joint Stock Company | 14.89 Billion CNY | -323.409% |
Yifeng Pharmacy Chain Co., Ltd. | 13.68 Billion CNY | -360.703% |
Yunnan Jianzhijia Health-Chain Co., Ltd. | 7.1 Billion CNY | -787.737% |